Title : Long-term outcomes of galantamine treatment in patients with Alzheimer disease.

Pub. Date : 2004 Sep-Oct

PMID : 15353385






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Patients taking galantamine continuously throughout the double-blind and open-label studies (N=288) showed sustained cognitive benefits on ADAS-Cog/11 scores at 18.5 months. Galantamine alkylglycerone phosphate synthase Homo sapiens